Top Glove Corporation Bhd. (TGLVY)
OTCMKTS · Delayed Price · Currency is USD
0.5792
-0.0008 (-0.14%)
Oct 27, 2025, 2:23 PM EDT
TGLVY Market Cap
TGLVY has a market cap or net worth of $1.3 billion as of October 27, 2025. Its market cap has decreased by -33.08% in one year.
Market Cap
1.30B
Enterprise Value
1.38B
Revenue
825.90M
Ranking
n/a
PE Ratio
41.57
Stock Price
$0.58
Market Cap Chart
Since March 27, 2001, TGLVY's market cap has increased from 284.20K to 1.30B, an increase of 457,490.17%. That is a compound annual growth rate of 40.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 1.28B | -46.64% |
| Dec 31, 2024 | 2.40B | 52.87% |
| Dec 29, 2023 | 1.57B | -5.04% |
| Dec 30, 2022 | 1.65B | -66.76% |
| Dec 31, 2021 | 4.98B | -59.27% |
| Dec 31, 2020 | 12.22B | 315.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |